CTRI/2021/05/033309招募中未知
A Real world, prospective, observational, Investigator Initiated Trial to evaluate early discharge following Angio-Sealâ?¢ vascular closure device in patients undergoing percutaneous coronary intervention
Aditya Birla Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients meeting with following criteria to be included in the study:
- •1) Patients > 18 years of age
- •2) Patients suitable for percutaneous coronary intervention through femoral approach
- •3) Angio-Seal • deployment will be as the IFU approved for India.
- •4) Patient or Legally acceptable representative of patient willing to sign an Informed Consent Form indicating that they understand the purpose of and the procedures required for the trial and are willing to participate in the study
排除标准
- •Patients meeting with following criteria to be excluded from the study:
- •1) Pregnant/ lactating females
- •2) Patients having known allergy to collagen and/or collagen products, or polyglycolic or polylactic acid polymers
- •3) Patients with ST elevation MI
- •4) Patients with Heart failure
- •5) Presence of any other clinically significant disease or laboratory findings that in the Investigatorâ??s opinion may affect the study outcomes.
研究者
相似试验
已完成
不适用
Study on Medical Device.CTRI/2021/03/032112The Madras Medical Mission Hospital90
进行中(未招募)
4 期
To understand prescription pattern of HAPID�®CTRI/2021/07/034607Wockhardt Ltd
招募中
不适用
Clinical trial to observe the safety and effectiveness of acotiamide in patients with functional dyspepsiaCTRI/2017/11/010421Dr Reddys Laboratories Limited
已完成
不适用
Study of Venusia® Max Cream as Moisturizer in PsoriasisCTRI/2017/03/008023Dr Reddys Laboratories Ltd400
进行中(未招募)
4 期
A study to evaluate safety and effectiveness of Rivaroxaban (Xarelto®) forPrevention of Stroke and Systemic Embolism in IndianPatients with Non-valvular Atrial Fibrillation (NVAF)CTRI/2019/09/021158Bayer Zydus Pharma Private Limited
